Our Team

PhenoBiome was founded by a unique blend of pioneering scientists and accomplished entrepreneurs who bring decades of expertise and proven leadership to the health and technology sectors.

PARTNER WITH US

Brian Russon

CEO

Co-founder & CEO of PatientGenie, a digital health company transforming how patients access and engage with personalized care. Previously co-founded TruClinic, acquired by InTouch Health and later Teladoc. Former executive at PatientPing, Orion Health, Microsoft, and UnitedHealth Group.

Kait Mikes

COO

Co-founder and Vice President of Mycoregenix and Founder of Peak Performance Consulting. With over 11 years in healthcare, she has held leadership roles at J.P. Morgan and Enovate Medical, and served as a Strategy Consultant driving growth and innovation across the industry.

Didier Perez

PRESIDENT

Brings over 40 years of entrepreneurial and financial leadership across transportation, finance, and genomics. He has co-founded and led eight companies—achieving four successful exits. Didier combines strategic foresight with operational excellence to strengthen PhenoBiome’s mission.

Andrei Osterman, Ph.D.

CO-FOUNDER

Professor at Sanford Burnham Medical Research Institute for over 20 years and former Director at Integrated Genomics for 15 years. Published in Nature, Science, and the New England Journal of Medicine, with notable collaborations alongside Jeffrey I. Gordon, widely regarded as the father of the microbiome.

Dmitry Rodionov, Ph.D.

CO-FOUNDER

Assistant Professor at Sanford Burnham Medical Research Institute for 18 years. Published in Nature, Science, and the New England Journal of Medicine, and collaborated with Jeffrey I. Gordon, recognized as the father of the microbiome.

Strong Scientific Foundation

Our scientific expertise is exceptionally solid: PhenoBiome’s core platform was developed by our scientists over a 16-year period while at the prestigious Sanford Burnham Prebys Medical Discovery Institute. This extensive, dedicated research ensures our technology is grounded in unparalleled scientific rigor. The science team is composed of distinguished researchers whose groundbreaking work is featured in top-tier journals, including Nature and Science. Their foundational collaborations solidify our platform’s position at the very forefront of functional genomics.

Proven Commercial Leadership

The executive team combines our foundational scientific expertise with the commercial foresight needed to scale breakthrough technology. Our leaders possess decades of collective experience across healthcare and finance, including a proven track record of multiple successful startup exits and executive roles at major healthcare corporations. This expertise ensures our science translates reliably and efficiently into market-ready products.